Report Overview
Global Lithotripsy Devices Market size is expected to be worth around US$ 1.6 Billion by 2035 from US$ 2.5 Billion in 2025, growing at a CAGR of 4.7% during the forecast period from 2026 to 2035. In 2025, North America led the market, achieving over 41.5% share with a revenue of US$ 0.6 Billion.
The global lithotripsy devices market is witnessing steady growth, driven by the increasing prevalence of kidney stones and other urinary tract disorders, rising demand for minimally invasive treatment options, and continuous technological advancements in urology. Lithotripsy devices are medical systems designed to break down kidney, ureteral, and bladder stones into smaller fragments using shock waves or laser energy, enabling their natural passage or easier removal with minimal surgical intervention.
The growing incidence of lifestyle-related risk factors, including obesity, dehydration, and dietary changes, has significantly contributed to the rising burden of urolithiasis worldwide. This has accelerated the adoption of advanced lithotripsy technologies across hospitals, ambulatory surgical centers, and specialized urology clinics. Furthermore, improvements in imaging capabilities, precision targeting, and patient safety have enhanced the effectiveness of lithotripsy procedures while reducing recovery time and hospital stays.
Healthcare providers are increasingly investing in next-generation lithotripsy systems that offer improved treatment outcomes, greater operational efficiency, and enhanced patient comfort. The market is also benefiting from expanding healthcare infrastructure, increasing healthcare expenditure, and growing awareness regarding early diagnosis and treatment of urinary stone diseases, particularly in emerging economies.
With ongoing research and development activities, favorable reimbursement policies in developed regions, and the integration of innovative technologies, the lithotripsy devices market is expected to maintain positive growth momentum over the coming years. Manufacturers continue to focus on product innovation and strategic collaborations to strengthen their market presence and address the evolving needs of healthcare professionals and patients worldwide.
Click here for more information:
Key Takeaways
The global lithotripsy devices market is projected to grow from US$ 1.6 billion in 2025 to approximately US$ 2.5 billion by 2035, registering a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2026 to 2035.
By product type, Extracorporeal Shock Wave Lithotripters (ESWL) held the leading position in 2025, accounting for 62.8% of the overall market revenue.
Based on technology, Shock Wave Lithotripsy emerged as the dominant segment, capturing 58.4% of the global market share in 2025.
In terms of application, the kidney stones segment represented the largest share of the market, contributing 48.5% of total revenue in 2025.
Among end users, hospitals remained the primary contributors, holding 55.9% of the global market share in 2025 due to the widespread availability of advanced treatment infrastructure.
Regionally, North America dominated the global lithotripsy devices market in 2025, accounting for 41.5% of the total market share and generating approximately US$ 0.6 billion in revenue.
Key Market Segments
By Product Type
Extracorporeal Shock Wave Lithotripters
Intracorporeal Lithotripters
Laser Lithotripters
Electrohydraulic Lithotripters
Others
By Technology
Shock Wave Lithotripsy
Laser Lithotripsy
Others
By Application
Kidney Stones
Ureteral Stones
Bladder Stones
Gallbladder Stones
Pancreatic Stones
Others
By End User
Hospitals
Ambulatory Surgical Centers
Specialty Clinics (Urology, Gastroenterology)
Others
Market Key Players
Boston Scientific Corporation
Olympus Corporation
Dornier MedTech GmbH
Siemens Healthineers AG
Medispec Ltd.
Richard Wolf GmbH
STORZ Medical AG
Elmed Electronics & Medical Industry
DirexGroup
Allengers Medical Systems Ltd.
EDAP TMS S.A.
Cook Medical LLC
C. R. Bard Inc. (BD)
Karl Storz SE & Co. KG
EMS Electro Medical Systems S.A.
Others
Driver:
The increasing prevalence of kidney stone disease is a major driver of the lithotripsy devices market. Growing rates of obesity, diabetes, inadequate fluid intake, dietary changes, and sedentary lifestyles have significantly increased the incidence of urolithiasis worldwide. According to the U.S. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 11% of men and 6% of women in the United States experience kidney stones at least once during their lifetime. Furthermore, kidney stones frequently recur, creating a continuous demand for effective treatment technologies. Larger stones often require interventional procedures such as extracorporeal shock wave lithotripsy (ESWL) or laser lithotripsy when spontaneous passage is unlikely. Government health agencies also report that urinary stone disease is commonly associated with chronic conditions such as obesity, hypertension, diabetes, and recurrent urinary tract infections, expanding the eligible patient population for lithotripsy procedures. As healthcare providers increasingly prefer minimally invasive therapies that reduce hospitalization and accelerate recovery, demand for advanced lithotripsy systems continues to rise. The growing clinical burden of urinary stone disease, combined with increasing healthcare utilization for urological disorders, is expected to support sustained adoption of lithotripsy devices across hospitals and specialized urology centers.
Trend:
A prominent trend in the lithotripsy devices market is the increasing adoption of minimally invasive technologies that improve treatment precision while reducing patient recovery time. Healthcare providers are increasingly utilizing laser lithotripsy integrated with flexible ureteroscopy and advanced imaging systems to achieve higher stone fragmentation accuracy. Simultaneously, innovations in digital visualization, fiber-optic laser systems, and automated stone measurement technologies are enhancing procedural efficiency. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), computed tomography (CT) remains the primary imaging modality for urinary stone diagnosis, with approximately 70% of patients undergoing CT imaging around the time of diagnosis. Accurate imaging enables better treatment planning and improves lithotripsy outcomes. Government-supported research is also advancing artificial intelligence-based stone measurement and image analysis to support clinical decision-making. In addition, outpatient treatment models are becoming increasingly common as minimally invasive procedures reduce hospital stays and postoperative complications. These technological improvements are enabling healthcare providers to deliver more personalized and efficient stone management while improving patient experience and procedural success rates.
Restraint:
Despite continued demand for stone treatment, the lithotripsy devices market faces challenges from changing clinical preferences and procedural limitations. Extracorporeal shock wave lithotripsy (ESWL), although non-invasive, is not suitable for all patients because treatment success depends on stone size, density, and anatomical location. Many complex cases now require ureteroscopy with laser lithotripsy or percutaneous nephrolithotomy to achieve higher stone-free rates. According to the NIDDK's 2024 Urologic Diseases in America report, the proportion of urinary stone disease patients undergoing ESWL declined from 9% to 6% among adults aged 18–64 years between 2012 and 2021, while utilization among adults aged 65 years and older decreased from 5% to 3% during the same period. These shifts reflect evolving physician preferences toward alternative minimally invasive procedures with greater clinical effectiveness for difficult stone cases. Additionally, the high acquisition cost of advanced lithotripsy equipment, ongoing maintenance requirements, and the need for specialized operator training can limit adoption, particularly in resource-constrained healthcare systems and smaller medical facilities.
Opportunity:
Significant opportunities exist for lithotripsy device manufacturers as healthcare systems expand access to advanced urology services and early diagnosis programs. Government healthcare investments in diagnostic imaging, hospital modernization, and specialist care are improving patient access to minimally invasive stone management. Increasing awareness of kidney stone prevention and early intervention is encouraging patients to seek medical attention before complications develop. According to NIDDK, kidney stones affect approximately 11% of men and 6% of women in the United States, indicating a substantial patient population that may benefit from improved diagnostic and therapeutic technologies. Furthermore, government-funded research is supporting innovations in automated stone detection, artificial intelligence-assisted imaging analysis, and precision treatment planning to improve procedural outcomes. Expansion of ambulatory surgical centers and outpatient urology services also creates new opportunities for compact and efficient lithotripsy systems capable of delivering high-quality care outside traditional inpatient settings. As developing countries continue strengthening healthcare infrastructure and increasing access to specialized urological services, manufacturers have opportunities to introduce technologically advanced, cost-effective lithotripsy solutions that improve patient outcomes while reducing healthcare resource utilization.
Conclusion: The global lithotripsy devices market is poised for sustained growth, driven by the increasing prevalence of kidney stone disease, rising preference for minimally invasive treatment options, and continuous technological advancements in urology. Innovations in laser-based lithotripsy, imaging systems, and outpatient treatment approaches are enhancing clinical outcomes and patient convenience. Although high equipment costs and evolving treatment preferences present certain challenges, expanding healthcare infrastructure, greater awareness of early diagnosis, and ongoing investments in advanced urological care are creating significant growth opportunities. As healthcare providers increasingly adopt efficient and patient-centric stone management solutions, the lithotripsy devices market is expected to witness steady expansion, supported by continuous product innovation and improved access to specialized care across both developed and emerging healthcare markets.
Top comments (0)